Previous work in breast cancer tissue has identified multiple mutations along this pathway (including MAP2K4 and MAP2K7)54 and suggests that this mutation could act as a driver by altering function of the JNK pathway. This evidence concerns the gene MAP2K4 and breast carcinoma.